相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genetic etiology of isolated low HDL syndrome - Incidence and heterogeneity of efflux defects
Robert S. Kiss et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
CETP inhibition in cardiovascular risk management: a critical appraisal
R. P. F. Dullaart et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Correction of apolipoprotein A-I-mediated lipid efflux and high density lipoprotein particle formation in human Niemann-Pick type C disease fibroblasts
Emmanuel Boadu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Adiponectin is an important determinant of ApoA-I catabolism
Bruno Verges et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
F Matsuura et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Decreased high-density lipoprotein (HDL) particle size, preβ-, and large HDL subspecies concentration in Finnish low-HDL families -: Relationship with intima-media thickness
H Watanabe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
High-density lipoprotein (HDL) transport in the metabolic syndrome: Application of a new model for HDL particle kinetics
JY Ji et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I
IC Gelissen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages
M Duong et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus
R de Vries et al.
DIABETOLOGIA (2006)
Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: Role of CETP and triglycerides
R de Vries et al.
DIABETES (2005)
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence
ES Ford
DIABETES CARE (2005)
Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment
R de Vries et al.
DIABETOLOGIA (2005)
The metabolic syndrome: Time for a critical appraisal - Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
R Kahn et al.
DIABETES CARE (2005)
New model for kinetic studies of HDL metabolism in humans
M Chétiveaux et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Depletion of pre-β-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1-but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein
E Favari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I
KA Rye et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Is the decreased high-density lipoprotein cholesterol in the metabolic syndrome due to cellular lipid efflux defect?
MY Alenezi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
SM Grundy et al.
CIRCULATION (2004)
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women - The prospective EPIC (European Prospective Investigation into Cancer and Nutrition) - Norfolk population study
SM Boekholdt et al.
CIRCULATION (2004)
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
N Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter A1 and enhances cholesterol efflux from cells
JF Oram et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus:: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins
SE Borggreve et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects
N Fournier et al.
ATHEROSCLEROSIS (2003)
High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease
A Schlitt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy
IJAM Jonkers et al.
JOURNAL OF LIPID RESEARCH (2003)
The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia
GK Hovingh et al.
JOURNAL OF LIPID RESEARCH (2003)
Importance of different pathways of cellular cholesterol efflux
PG Yancey et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Influence of obesity and insulin sensitivity on phospholipid transfer protein activity
S Kaser et al.
DIABETOLOGIA (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
High density lipoproteins and arteriosclerosis - Role of cholesterol efflux and reverse cholesterol transport
A von Eckardstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice
R van Haperen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
